Article Details

Immunomic Therapeutics' CEO to Present at the 2nd Annual Glioblastoma Drug Development ...

Retrieved on: 2020-12-01 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Immunomic Therapeutics' CEO to Present at the 2nd Annual Glioblastoma Drug Development .... View article details on hiswai:

Excerpt

<b>Immunomic Therapeutics</b>, Inc. (ITI) announced today that it will be presenting at the 2 nd Annual Glioblastoma Drug Development Virtual Summit.

Article found on: www.oaoa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo